San Juan County, Colorado, is one of the most vaccinated counties in the U.S. Leaders across the country continue to expound on the vaccine as the path forward in the pandemic. But San Juan’s experience the past few weeks with its first covid hospitalizations shows that, even with an extremely vaccinated population, masks are still necessary.
KHN gives readers a chance to comment on a recent batch of stories.
Patients sickened in heat waves, flooding and wildfire have raised awareness of climate change’s impact on health. Now, some hospitals are building solar panels and cutting waste to reduce their own carbon footprints, with support from a new office at the U.S. Department of Health and Human Services. But the industry is moving slowly.
More than 2 million low-income adults are uninsured because their states have not accepted Medicaid expansion under the Affordable Care Act. Congressional Democrats want to offer them coverage in the massive spending bill being debated, but competition to get into that package is fierce.
Efforts to give 2.2 million Americans health insurance hang in the balance as Congress debates a massive spending bill. The so-called Medicaid gap is felt most acutely in Texas, where about half of those who stand to gain coverage live.
The pandemic is devastating rural America, where lower vaccination rates are compounding the already limited medical care.
A patient from Dallas got a PCR test in a free-standing suburban emergency room. The out-of-network charge: $54,000.
Britney Spears was forced into psychiatric care — and compelled to pay for it. That can happen to any patient who has an episode of serious mental illness, piling financial woes onto their stress and vulnerability.
The condition can be an early signal of Alzheimer’s disease, but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.
The ad, advanced by a right-leaning seniors advocacy organization, mischaracterizes proposals to bargain on drug prices, regarding both the effects on the Medicare program and on beneficiaries.
